3-Fluoromethamphetamine

3-Fluoromethamphetamine
Ball-and-stick model of the 3-fluoromethamphetamine molecule
Legal status
Legal status
  • CA: Schedule I[1]
  • DE: Anlage I (Authorized scientific use only)
  • UK: Class A
  • US: Unscheduled
Identifiers
  • (RS)-1-(3-fluorophenyl)-N-methylpropan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC10H14FN
Molar mass167.227 g·mol−1
3D model (JSmol)
  • FC1=CC=CC(CC(NC)C)=C1
  • InChI=1S/C10H14FN/c1-8(12-2)6-9-4-3-5-10(11)7-9/h3-5,7-8,12H,6H2,1-2H3
  • Key:RRVAUTPWWWFYQT-UHFFFAOYSA-N

3-Fluoromethamphetamine (3-FMA) is a stimulant drug related to methamphetamine and 3-fluoroamphetamine. It has been sold online as a designer drug.[2][3][4][5]

Canada

As of 1996, 3-FMA is a controlled substance in Canada, due to being an analog of methamphetamine.[1]

China

As of October 2015, 3-FMA is a controlled substance in China.[6]

United States

As a close analog of scheduled controlled substance,[7] sale or possession of 3-FMA could be potentially be prosecuted under the Federal Analogue Act.[8]

See also

References

  1. ^ a b Branch, Legislative Services (2022-03-31). "Consolidated federal laws of Canada, Controlled Drugs and Substances Act". laws-lois.justice.gc.ca. Archived from the original on 2022-06-11. Retrieved 2022-08-11.
  2. ^ Westphal F, Rösner P, Junge T (January 2010). "Differentiation of regioisomeric ring-substituted fluorophenethylamines with product ion spectrometry". Forensic Science International. 194 (1–3): 53–9. doi:10.1016/j.forsciint.2009.10.007. PMID 19900772.
  3. ^ Nakanishi K, Miki A, Zaitsu K, Kamata H, Shima N, Kamata T, et al. (April 2012). "Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View, and the Emit assays for use in drug enforcement". Forensic Science International. 217 (1–3): 174–81. doi:10.1016/j.forsciint.2011.11.003. PMID 22154438.
  4. ^ Kauppila TJ, Flink A, Haapala M, Laakkonen UM, Aalberg L, Ketola RA, Kostiainen R (July 2011). "Desorption atmospheric pressure photoionization-mass spectrometry in routine analysis of confiscated drugs". Forensic Science International. 210 (1–3): 206–12. doi:10.1016/j.forsciint.2011.03.018. PMID 21474259.
  5. ^ Nakazono Y, Tsujikawa K, Kuwayama K, Kanamori T, Iwata YT, Miyamoto K, Kasuya F, Inoue H (July 2013). "Differentiation of regioisomeric fluoroamphetamine analogs by gas chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry". Forensic Toxicology. 31 (2): 241–250. doi:10.1007/s11419-013-0184-7. S2CID 23323323.
  6. ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.
  7. ^ Rösner P, Quednow B, Girreser U, Junge T (March 2005). "Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues (designer drugs)". Forensic Science International. 148 (2–3): 143–56. doi:10.1016/j.forsciint.2004.05.003. PMID 15639609.
  8. ^ "Federal Controlled Substance Analogue Act Summary". Erowid Analog Law Vault.
Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.